glp-1 and crohn's disease Ever wondered how obesity, IBD, GLP‑1 medication all fit together? If so, come along to this month's IBD patient meeting, where the group will be joined by Dr Chris Roberts for The alleviating effect and mechanism

But retatrutide may be even more effective , for several reasons: Glucagon receptor activation promotes hepatic fat oxidation Reduces liver fat accumulation more robustly Improves liver enzyme levels (ALT, AST) In a subgroup analysis of the retatrutide Phase 2 trial: Patients with suspected NAFLD showed a 70%+ reduction in liver fat content , measured by MRI-PDFF These effects surpassed the reductions seen with tirzepatide and semaglutide in comparable studies Another study showed that 93% of patients on the highest dose of retatrutide had 100% resolution of fatty liver

We review your medical history, perform a physical exam, and run lab tests

4:e6453

[DOI] [PMC free article] [PubMed] [Google Scholar] Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis